Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T14:15:51.356Z.
Calculation as of: 2026-10-06T14:15:51.356Z.
Quote observation: 2026-10-06T14:15:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 29544bddba9647c45f1d116a926e76fce0232fba061b4e126f75ac7ab8440d73
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$847.33M
EBITDA Yield
N/A
TTM Avg
3.15%
3Y Avg
3.15%
5Y Avg
3.15%
Market Cap
$868.65M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$878.06M
EBITDA Yield
17.07%
TTM Avg
17.01%
3Y Avg
17.01%
5Y Avg
17.01%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | $844.91M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $847.33M | N/A | 3.15% | 3.15% | 3.15% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $868.65M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $826.99M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $878.06M | 17.07% | 17.01% | 17.01% | 17.01% |
| Apnimed, Inc. (APMD)vs › | $817.57M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $818.57M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | N/A | 123.97% | 123.97% | 123.97% |
| InMode Ltd. (INMD)vs › | $809.04M | 16.75% | 14.19% | 12.45% | 9.40% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $808.29M | N/A | 1.34% | 2.25% | 2.25% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
